Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gevokizumab in controlled non-infectious uveitis
NCT01747538Phase 3Terminated
- Sponsor
- XOMA
- Start
- Oct 2012
- Primary completion
- Jun 2016
- Modality
- Monoclonal Antibodies
- Countries
- 22
01
Overview
A Phase 3 trial of gevokizumab in noninfectious uveitis (NIU), sponsored by XOMA. Started Oct 2012; status: terminated.
02
Drugs
gevokizumab
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT01747538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01747538.